Jinshanyun's information technology company increased its capital to USD 500 million. Tianyancha App shows that Jinshan Yun (Hainan Yangpu) Information Technology Co., Ltd. has undergone industrial and commercial changes recently, and its registered capital has increased from USD 400 million to USD 500 million. The company was established in August 2022, and its legal representative is Zou Tao. Its business scope is Internet domain name registration service, computer software and hardware and auxiliary equipment wholesale, technical service, technical development, technical consultation, technical exchange, technology transfer, technology promotion, information system integration service, software development and software sales, and it is wholly owned by Jinshanyun Co., Ltd.Market News: The Bank of Japan will consider not raising interest rates at its next policy meeting.
District 9 of Beijing issued a gale warning. At present, Huairou, Yanqing, Changping, Haidian, Mentougou, Fangshan, Chaoyang, Pinggu and Shijingshan have issued a blue gale warning signal. Today, the wind-cold effect is obvious, and the body feels cold. We should pay attention to wind and cold protection, and stay away from temporary structures such as billboards and tall trees, and do a good job in outdoor aerial work.Ministry of Finance of Thailand: It is estimated that the global minimum corporate tax of 15% will be implemented from January 2025.Tongda shares: Huashengbaili plans to reduce its shareholding by no more than 3%. Datong shares announced that Huashengbaili, a shareholder holding more than 5%, plans to reduce its shareholding by centralized bidding and block trading within three months after 15 trading days from the disclosure date of this announcement, with a total shareholding of no more than 2.664 million shares, accounting for 3% of the company's total share capital.
Asia-Pacific Pharmaceuticals: The new specifications of cefmetazole sodium for injection were approved, and Asia-Pacific Pharmaceuticals announced that the company was approved by National Medical Products Administration, and the new specifications of cefmetazole sodium for injection were 0.5g and 2g, which further enriched the product categories on the basis of the original 1g specifications. The annual sales income of this drug in 2023 was 96.3946 million yuan, accounting for 22.92% of the company's operating income. New specifications are helpful to market promotion and competitiveness improvement, but drug production and sales are affected by policies and market environment, and there are uncertainties.The General Administration of Market Supervision launched a pilot program to deepen credit repair. The gold T+D of Shanghai Gold Exchange fell by 1.01% to 617.82 yuan/gram at the beginning of trading on Friday, December 13th. Silver T+D of Shanghai Gold Exchange fell 1.27% to 7722.0 yuan/kg at the beginning of trading on Friday, December 13th.Weixing Co., Ltd.: Compared with the first half of the year, the growth rate of acquiring orders in the second half of the year gradually declined, but the overall growth rate still maintained. Weixing Co., Ltd. recently said in a conference call that due to the influence of the terminal consumption boom, downstream brand customers were cautious in placing orders, and the growth rate of acquiring orders in the second half of the year gradually declined compared with the first half of the year, but the overall growth rate still maintained. In recent years, the company has mainly focused on promoting globalization strategy, intelligent manufacturing strategy and improving manufacturing level, technical level and product quality, and achieved certain results.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
Strategy guide 12-14